CRON Cronos Group: Company Short-Term Debt

Corporate emblem and logo of Cronos (CRON)

Cronos Group Inc. (CRON) enjoys global recognition due to its uncompromising product quality and operational transparency, as evidenced by the market valuation on the GURU.Markets price chart, where the indicator stands at 0.00. The business's success relies on the pace of decriminalization in Western countries and support from major funds. Meanwhile, the Canadian asset is battling pricing pressure, maintaining resilience through capital injections from tobacco allies.

thecronosgroup.com (CRON) - Company Short-Term Loans and Borrowings from 07/04/2022 to 10/29/2026

Summary analytical data breakdowns for Cronos Corp (CRON)

- stock price and consensus target price:
Stock Price Cronos Group|CRON - Consensus Target
- company stock capitalization data:
Market Value Cronos Group Inc.|CRON - Total Enterprise Value
- shareholders' equity book value data:
Accounting Value per Share Cronos Group|CRON - Accounting Value of Company|Market Capitalization to Book Value Ratio thecronosgroup.com|CRON - Total Asset Value of Company
- debt and liquidity details:
Total Debt to Capital Cronos Group Inc.|CRON - Long-Term Debt to Capital|Short-Term Debt to Equity Cronos Group Inc.|CRON - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Cronos Group Inc.|CRON - Company Long-Term Liabilities|Company Short-Term Debts Cronos Group
General company analysis:CRON - Cronos Group
Manufactured products of Cronos Group Inc.

This indicator aggregates all Cronos Group Inc. (CRON) liabilities with a maturity of up to one year. A decline in this metric signals a healthier balance sheet, although an excessive minimum may indicate limited access to credit. Amidst the business transformation toward medical formats, debt optimization frees up resources for R&D. The trend in total short-term debt confirms the effectiveness of the current financial strategy.

Competitor analysis

Indivior - Company Short-Term Debts|Collegium Pharma (COLL) - Company Current Liabilities|Tweed (CGC) - Company Short-Term Debt|Short-Term Debt Canna Cabana (HITI)|Company Current Liabilities ACB|ACHV: Company Short-Term Loans and Borrowings|Company Short-Term Debts SKYE|ANEB: Current Liabilities|Company Short-Term Debts INCR (InterCure)|Company Short-Term Debts Nutriband Inc NTRB|NSRX - Company Short-Term Debt|Company Short-Term Loans and Borrowings IGC (IGC Pharma, Inc.)|mirapharmaceuticals.com (MIRA) - Company Short-Term Debt|Company Current Liabilities Flora Growth Corp|IMCC (IM Cannabis Corp) - Company Short-Term Debts|Company Current Liabilities Adial (ADIL)|Company Short-Term Debt Artelo Biosciences (ARTL)|ENSC (ensysce.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Titan Pharmaceuticals, Inc. TTNP|Greenlane Holdings, Inc. (GNLN) - Short-Term Debt|INM - Company Short-Term Debt|AKAN (Akanda Inc) - Company Short-Term Indebtedness|Enveric Biosciences (ENVB) - Company Short-Term Debt|Short-Term Debt Bright Green Corporation (BGXX)|Company Short-Term Debt Hempacco